SMAD6 and glioblastoma: Demonstrating the role played by TGF-β-Smad1/5 signaling in this process, knockdown of the TGF-β type I receptor ALK1 or overexpression of the inhibitory Smad6 reduced endothelialisation and impaired glioblastoma progression.